James Kahn, MD, MPH

James Kahn
Global Health Sciences Faculty Affiliate

Phone: 415-476-6642
UCSF Box: 0936
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start End
Study of the Cost and Efficiency of HIV Prevention in Developing Countries PHS Secretary for Health Kenya; Uganda; Tanzania; South Africa; Belarus HIV/AIDS, Health Economics and Effectiveness
Building Capacity in the Estimation of Unmet Need for HIV Care U.S. Health Resources and Services Administration United States HIV/AIDS, Epidemiology and Surveillance
Axios Program Evaluation Program Axios Foundation, Inc. South Africa; Nigeria; Pakistan; Malaysia; Thailand; Philippines; United Arab Emirates Health Economics and Effectiveness, Access or Barriers to Care
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse [II] Stanford University United States HIV/AIDS, Health Economics and Effectiveness
California Health Care Policy Research Program University of California Berkeley United States Health Economics and Effectiveness
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) University of Minnesota United States HIV/AIDS, Pharmacology and Drug Treatment, Health Economics and Effectiveness
High-Quality, High Volume Cataract Surgery at Aravind as a Model for Male Circumcision Bill & Melinda Gates Foundation India HIV/AIDS, Surgery and Anesthesia, Risk Reduction and Prevention
Congenital Syphilis Elimination Cost-Effectiveness Analysis World Health Organization (WHO) Burundi; Comoros; Djibouti; Madagascar; Malawi; Mauritius; Mozambique; Rwanda; Tanzania; Zambia; Zimbabwe; Cameroon; Central African Republic; Chad; Congo (Brazzaville); Gabon; Sao Tome and Principe; Sudan; Tunisia; Botswana; Namibia; South Africa; Swaziland; Benin; Burkina Faso; Ivory Coast; Ghana; Guinea; Mali; Nigeria; Sierra Leone; Togo; Kazakhstan; Kyrgyzstan; Uzbekistan; China; Mongolia; Afghanistan; Bangladesh; India; Maldives; Nepal; Sri Lanka; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Myanmar; Thailand; Philippines; Jordan; Oman; Saudi Arabia; Belarus; Czech Republic; Estonia; Germany; Hungary; Lithuania; Macedonia; Moldova; Romania; United Kingdom; Costa Rica; El Salvador; Guatemala; Honduras; Mexico; Panama; Argentina; Bolivia; Brazil; Chile; Colombia; Ecuador; Guyana; Paraguay; Peru; Uruguay; Antigua and Barbuda; Cuba; Dominica; Dominican Republic; Grenada; Trinidad and Tobago; Fiji; Kiribati; Papua New Guinea Sexually Transmitted Infections (STIs), Health Economics and Effectiveness
GHER-Global Health Effectiveness Review Henry J. Kaiser Family Foundation United States Health Economics and Effectiveness
Making Better Decision: Policy Modeling for AIDS and Drug Abuse [I] Stanford University United States HIV/AIDS, Health Economics and Effectiveness, Substance Abuse
Global Health Comparative Effectiveness: A Data Synthesis Method Applied to HIV NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Health Economics and Effectiveness
Unit Cost Reference Database University of Washington (UW) United States Health Economics and Effectiveness
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse Stanford University United States HIV/AIDS, Health Economics and Effectiveness, Substance Abuse
Unit Cost Reference Database University of Washington (UW) United States Health Economics and Effectiveness
Economic Analysis for Prevention of Disease (EMPoD) Centers for Disease Control and Prevention (CDC) United States Health Economics and Effectiveness
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse Stanford University United States HIV/AIDS, Tuberculosis, Health Economics and Effectiveness